Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women
Start here
A structured clinical-digital hybrid program delivered GLP-1 receptor agonist therapy to 8,127 women from a community-based population over 6 months, with monthly clinician-led review, supervised weight confirmation and structured side effect mitigation. Of 16,121 individuals meeting initial screening criteria, 4,025 were excluded for not completing baseline blood testing and 308 after clinical review. Mean baseline weight was 104.2 kg and mean BMI 38.2 kg per m2, with 95.5% meeting criteria for class I to III obesity. It is one of the largest real-world evaluations of GLP-1RA therapy in a female community cohort and complements trial findings that enrolled predominantly male populations.
Excerpted from nature.com
Coverage timeline
Follow the coverage to see the different angles.
- nature.comPickReal-world, digital-first delivery of GLP-1 receptor agonist therapy in women
A structured clinical-digital hybrid program delivered GLP-1 receptor agonist therapy to 8,127 women from a community-based population over 6 months, with monthly clinician-led review, supervised weight confirmation and structured side effect mitigation. Of 16,121 individuals meeting initial screening criteria, 4,025 were excluded for not completing baseline blood testing and 308 after clinical review. Mean baseline weight was 104.2 kg and mean BMI 38.2 kg per m2, with 95.5% meeting criteria for class I to III obesity. It is one of the largest real-world evaluations of GLP-1RA therapy in a female community cohort and complements trial findings that enrolled predominantly male populations.
Heat trend for this story
Heat now 7·Peak in the comparable set 9 (Oct 13 14:00)·Change over 24h in the comparable set –
The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's heat; the left and right arrow keys work too.